Amplifica Announces New Compound AMP-303

Amplifica has been very active in the first half of 2023. They announced the addition of SCUBE 3 (AMP-601) to their pipeline back in January, and announced osteopontin (AMP-203) in June as another compound discovered from Maksim Plikus’ research into hairy moles and hair growth. Now, just a week after the AMP-203 announcement, Amplifica has issued a press release for the initiation of a clinical trial for new mystery compound AMP-303. The front page and Articles page has the full Amplifica story.

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.